MTOR and neurodegenerative disease: Based on the same signaling pathways, like PI3K/AKT/mTOR (targeted by miR-129-5p), experimental studies are trying to improve the therapeutic means based on RNA that could lead to personalized, targeted, therapeutic management, with better specificity than classical treatments for digestive cancers and neurodegenerative diseases.